Læknablaðið - 15.09.2006, Síða 35

ASPIRIVK (TIOTROPIUM)
Meira ioft i lungun
Frelsi
SPIRIVA"
er grunnurinn í
meðhöndlun á LLT
1.2)
A Minnkar mæði við áreynslu31
A Eykur úthald við áreynslu31
A Fækkar versnunum og innlögnum
vegna þeirra’
A Eykur lífsgæði sjúklings61
Heimildir: I) Medicinsk Kompendium 2004; bls 1331. 2) Tashkin et al. Review.The Role oí Long-Acting Bronchodilators in the Management of Stable COPD. CHEST 2004;125:249-259. 3) O'Donnell et al. Effects of tiotropium on lung hyperinflation,
dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840. 4) Casaburi et al.A long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217-224. 5) Vincken et al. Improved health
outcomes in patients with COPD during I years treatment with tiotropium. Eur Respir J 2002:19:209-216.

Sérlyfjatexti á bls. 656
UmboðsaðiliiVistor hf.
Hörgatúni 2,210 Garðabær
Sími: 535 7000, www.pfizer.is
Boehringer
lllllP Ingelheim